Page 39 - Relapse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.

DEAR ABBY: I was married for 20 years. We met when I was 13. Our relationship continued through high school and college. We later married and had three children. I

DISCOMS trial has provided data to guide decisions, now it's all about individualized discussions

Following the switch from natalizumab, patients with multiple sclerosis on anti-CD20 therapies like rituximab demonstrated significant reductions in annualized relapse rate.

Specialists engage in a conversation regarding the treatment duration and the effectiveness of the current two-year approach.